𝔖 Bobbio Scriptorium
✦   LIBER   ✦

VEGF-mediated tumour angiogenesis: a new target for cancer therapy

✍ Scribed by Georg Martiny-Baron; Dieter Marmé

Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
510 KB
Volume
6
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.

✦ Synopsis

Considerable evidence is gathering for the involvement of vascular endothelial growth factor (VEGF) in the vascularization and growth of primary tumours as well as in the formation of metastases. The expression of VEGF depends on activated oncogenes and inactivated tumour suppressor genes as well as several other factors (e.g. growth factors, tumour promoters and hypoxia). Substantial expression of the receptors for VEGF is restricted mainly to the tumour blood vessels. The causal involvement of this angiogenic factor in the progression of disease has been successfully evaluated by means of monoclonal antibodies against VEGF, dominant-negative receptor mutants and the use of antisense oligonucleotides against the VEGF mRNA. Thus, the VEGF signalling system seems to be an appropriate target to inhibit tumour angiogenesis and metastases formation.

📜 SIMILAR VOLUMES

Angiogenesis as a strategic target for p
Angiogenesis as a strategic target for prostate cancer therapy
✍ Yong Li; Paul J. Cozzi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB

## Abstract It is becoming increasingly clear that angiogenesis plays a crucial role in prostate cancer (CaP) survival, progression, and metastasis. Tumor angiogenesis is a hallmark of advanced cancers and an attractive treatment target in multiple solid tumors. By understanding the molecular basis

A New Era for Cancer Treatment: Gold-Nan
A New Era for Cancer Treatment: Gold-Nanoparticle-Mediated Thermal Therapies
✍ Laura C. Kennedy; Lissett R. Bickford; Nastassja A. Lewinski; Andrew J. Coughlin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 824 KB

## Abstract Nanotechnology‐based cancer treatment approaches potentially provide localized, targeted therapies that aim to enhance efficacy, reduce side effects, and improve patient quality of life. Gold‐nanoparticle‐mediated hyperthermia shows particular promise in animal studies, and early clinic

CD40-mediated death and cytokine secreti
CD40-mediated death and cytokine secretion in colorectal cancer: A potential target for inflammatory tumour cell killing
✍ Nikolaos T. Georgopoulos; Alison Merrick; Nigel Scott; Peter J. Selby; Alan Melc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 493 KB

## Abstract CD40, a member of the tumour necrosis factor family, is expressed in a variety of epithelial cells. Although soluble CD40 agonists are growth‐inhibitory, membrane‐presented CD40 ligand (CD40L) induces extensive apoptosis in carcinoma cells. This study investigated whether CD40 is expres